The STATES 2.0 Act, a bipartisan bill, would remove marijuana from the Controlled Substances Act, allowing states to regulate ...

The DEA’s potential rescheduling of cannabis to a Schedule III drug could ease restrictions, boosting research and offering ...

National pharmaceutical retailer Walgreens has agreed to pay at least $300 million to settle allegations it illegally fulfilled millions of invalid controlled substance prescriptions for more than ...

A Houston pharmacy, Nnwood Pharmacy, and its owners, Cheryl Brew Greenleaf and Wendell Kirk Greenleaf, are under investigation for allegedly dispensing controlled substances like hydrocodone and ...

In a landmark victory for justice and public health, Rabin Kammerer Johnson (RKJ) and Searcy Denney Scarola Barnhart & ...

President Donald Trump 's pick to run the Drug Enforcement Administration (DEA) is apparently considering a proposal to ...

Outdated federal policies concerning cannabis have impeded research and prevented patients from accessing the full ...